X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

The US Intends To Implement Federal Employee Vaccination Law

Content Team by Content Team
12th April 2022
in News
The UK begins the biggest ever immunization program

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

The Justice Department petitioned a federal appeals court on April 11 to enable the Biden administration to begin implementing a federal employee immunisation mandate that was stopped by a lower court judge in January.

President Joe Biden’s executive order ordering that government civilian employees be inoculated against COVID-19 was reinstated by a panel of the 5th U.S. Circuit Court of Appeals. Until the court takes further procedural steps, the White House advised federal agencies this week that they should continue to take no actions to enforce or execute the COVID-19 vaccination requirement.

The Justice Department urged the appeals court on Monday to take the necessary steps to allow the government to resume enforcing President Joe Biden’s executive order. It said that the appeals court should make its decision as soon as possible so that the ruling can take effect. It said that the damage to the public interest and the government shows that this is the right thing to do.

Biden announced in September that he would order roughly 3.5 million federal employees to get immunised by Nov. 22 unless they have a religious or medical exemption, or face penalty or dismissal. The administration claimed that the federal trial court lacked jurisdiction over the case. Employees were required to file a grievance under the Civil Service Reform Act, it told the appeals court (CSRA).

According to the panel’s 2-1 ruling, the plaintiffs attempted to evade the CSRA’s exclusive review scheme. More than 93 percent of government workers have gotten at least one vaccination, with 98 percent having been vaccinated or requesting a religious or medical exemption, as per the White House.

Biden’s COVID-19 vaccination-or-testing rule for major corporations was halted by the US Supreme Court in mid-January. A varied federal vaccine mandate for healthcare establishments was approved by the court. In December, a federal judge delayed a third major vaccine demand targeted at employees of government contractors such as airlines and manufacturers.

Previous Post

NICE Asks Gilead To Lower Trodelvy Rate And Bans Eczema Meds

Next Post

Aptar Pharma Returns In-Person to Pharmapack 2022 as Premium Partner to Showcase Expanded Drug Delivery Solutions Offering

Related Posts

idiopathic pulmonary fibrosis
Americas

US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

9th October 2025
Tissue Repair Drug
Clinical Trials

FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

7th October 2025
FastTrack Review
Americas

US FDA Launches Fast-Track Review Scheme for Generic Drugs

7th October 2025
AI Based Drug Discovery
Drug Development

Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

1st October 2025
API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
Next Post
Aptar Pharma Returns In-Person to Pharmapack 2022 as Premium Partner to Showcase Expanded Drug Delivery Solutions Offering

Aptar Pharma Returns In-Person to Pharmapack 2022 as Premium Partner to Showcase Expanded Drug Delivery Solutions Offering

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In